A recent retrospective analysis examining 38 patients undergoing lung volume reduction found that the robotic approach was associated with a shorter duration of chest drainage and reduced reliance on early postoperative opioid analgesia compared to the video-assisted method.
The study, conducted at a single center, compared outcomes for 21 patients treated with robotic-assisted thoracic surgery (RATS) against 17 patients treated with the VATS approach. Researchers assessed several key postoperative indicators, including the number of days a chest drain was required, total length of hospital stay, reported pain levels, and cumulative opioid consumption measured in oral morphine-equivalent milligrams during the initial 72 hours following the procedure.
A primary finding of the analysis was the difference in chest drain duration between the two cohorts. Patients who underwent robotic-assisted procedures required the chest drain for an average of 4.6 ± 1.9 days, which was statistically significantly shorter than the 10.8 ± 6.1 days observed in the VATS cohort, with a p-value of 0.002.
In terms of analgesic requirements, the study observed that opioid use over the first 72 hours post-surgery was significantly lower among patients in the RATS group, who required an average of 38 ± 12 mg, compared to 54 ± 18 mg for those in the VATS group (p = 0.01). Despite this clear difference in medication requirements, patient-reported pain scores were found to be comparable between the two groups at all measured time points throughout the recovery period.
The duration of hospital stay showed a numerical trend toward shorter recovery for the RATS group, with a median stay of 8.0 days compared to 12.0 days for the VATS group. However, this finding did not reach statistical significance, with a p-value of 0.14. The authors reported that baseline demographics and physiological parameters were broadly similar between the study populations.
The research team also conducted an exploratory health-economic analysis using institutional costing data to evaluate the broader impact of these surgical approaches. While the preliminary model suggested potential cost neutrality, the authors emphasized that these estimates are strictly hypothesis-generating and require further investigation to confirm economic viability.
The authors concluded that while robotic-assisted LVRS demonstrates promising benefits in reducing chest drain duration and lowering early opioid requirements, the findings remain preliminary. Due to the study’s nature as a retrospective, single-center analysis, these observations require confirmation through larger, adjusted prospective studies to determine if these benefits are consistent across wider patient populations and clinical settings.
Subject of Research: Comparison of robotic and video-assisted surgical outcomes for lung volume reduction.
Article Title: Perioperative outcomes of robotic-assisted versus video-assisted thoracoscopic lung volume reduction surgery
Article References: Ahmed, H., Patel, A., Fallouh, H., & Naidu, B. (2026). Perioperative outcomes of robotic-assisted versus video-assisted thoracoscopic lung volume reduction surgery. Journal of Cardiothoracic Surgery. https://doi.org/10.1186/s13019-026-04563-2
Image Credits: AI Generated
DOI: 10.1186/s13019-026-04563-2
Keywords: Thoracic surgery, Lung volume reduction surgery, Robotic-assisted thoracic surgery, Video-assisted thoracoscopic surgery, Chest drain duration, Postoperative pain, Opioid consumption, Retrospective analysis, Surgical outcomes, Hospital stay, COPD, Minimally invasive surgery, Cardiothoracic surgery, Healthcare efficiency, Perioperative care
News Source: Ophelia Keating. (November 18, 2026). Robotic-Assisted Lung Volume Reduction Surgery Linked to Shorter Chest Drain Duration. Scienmag.



